Aolei Niu

1.2k total citations
17 papers, 825 citations indexed

About

Aolei Niu is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, Aolei Niu has authored 17 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Aolei Niu's work include Immune cells in cancer (6 papers), Acute Kidney Injury Research (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Aolei Niu is often cited by papers focused on Immune cells in cancer (6 papers), Acute Kidney Injury Research (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Aolei Niu collaborates with scholars based in United States, China and Australia. Aolei Niu's co-authors include Raymond C. Harris, Yinqiu Wang, Ming‐Zhi Zhang, Suwan Wang, Xiaofeng Fan, Xin Wang, Bing Yao, Yu Pan, Kensuke Sasaki and Shirong Cao and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Diabetes.

In The Last Decade

Aolei Niu

17 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aolei Niu United States 14 305 295 234 109 99 17 825
Chun‐Tao Lei China 16 310 1.0× 353 1.2× 145 0.6× 110 1.0× 86 0.9× 26 908
Jiafa Ren United States 20 320 1.0× 465 1.6× 258 1.1× 112 1.0× 116 1.2× 38 1.2k
Zhuanli Zhou China 11 329 1.1× 541 1.8× 130 0.6× 130 1.2× 79 0.8× 13 887
Lirong Hao China 17 199 0.7× 287 1.0× 131 0.6× 65 0.6× 91 0.9× 34 763
Khaled Khazim Israel 13 195 0.6× 312 1.1× 195 0.8× 75 0.7× 77 0.8× 16 878
Akira Mima Japan 12 235 0.8× 310 1.1× 105 0.4× 98 0.9× 116 1.2× 19 903
Shirong Cao United States 15 240 0.8× 254 0.9× 94 0.4× 170 1.6× 70 0.7× 23 690
Xuewang Li China 17 394 1.3× 292 1.0× 136 0.6× 105 1.0× 82 0.8× 81 915
Dhanunjay Mukhi United States 16 299 1.0× 371 1.3× 88 0.4× 138 1.3× 89 0.9× 27 853
Xiaogang Du China 16 204 0.7× 245 0.8× 122 0.5× 203 1.9× 123 1.2× 44 791

Countries citing papers authored by Aolei Niu

Since Specialization
Citations

This map shows the geographic impact of Aolei Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aolei Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aolei Niu more than expected).

Fields of papers citing papers by Aolei Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aolei Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aolei Niu. The network helps show where Aolei Niu may publish in the future.

Co-authorship network of co-authors of Aolei Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Aolei Niu. A scholar is included among the top collaborators of Aolei Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aolei Niu. Aolei Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pan, Yu, Shirong Cao, Yinqiu Wang, et al.. (2025). Myeloid EGFR deficiency accelerates recovery from AKI via macrophage efferocytosis and neutrophil apoptosis. Nature Communications. 16(1). 4563–4563. 1 indexed citations
2.
Cao, Shirong, Yu Pan, Andrew S. Terker, et al.. (2023). Epidermal growth factor receptor activation is essential for kidney fibrosis development. Nature Communications. 14(1). 7357–7357. 23 indexed citations
3.
Sasaki, Kensuke, Andrew S. Terker, Jiaqi Tang, et al.. (2022). Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis. JCI Insight. 7(4). 12 indexed citations
4.
Pan, Yu, Shirong Cao, Jiaqi Tang, et al.. (2022). Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice. Journal of Clinical Investigation. 132(9). 43 indexed citations
5.
Cao, Shirong, Yu Pan, Jiaqi Tang, et al.. (2022). EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance. Nature Communications. 13(1). 4684–4684. 48 indexed citations
6.
Wang, Yinqiu, Aolei Niu, Yu Pan, et al.. (2021). Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq. Diabetes. 70(10). 2377–2390. 14 indexed citations
7.
Pan, Yu, Shirong Cao, Andrew S. Terker, et al.. (2021). Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury. Kidney International. 101(1). 79–91. 23 indexed citations
8.
Sasaki, Kensuke, Andrew S. Terker, Yu Pan, et al.. (2021). Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation. Journal of the American Society of Nephrology. 32(5). 1037–1052. 49 indexed citations
9.
Terker, Andrew S., Kensuke Sasaki, Juan Pablo Arroyo, et al.. (2021). Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction. American Journal of Physiology-Renal Physiology. 320(4). F569–F577. 10 indexed citations
10.
Li, Yan, Yu Pan, Shirong Cao, et al.. (2020). Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy. Diabetes. 70(2). 562–576. 55 indexed citations
11.
Zhang, Ming‐Zhi, Kensuke Sasaki, Li Yan, et al.. (2019). The Role of the EGF Receptor in Sex Differences in Kidney Injury. Journal of the American Society of Nephrology. 30(9). 1659–1673. 20 indexed citations
12.
Chung, Sungjin, Jessica M. Overstreet, Yan Li, et al.. (2018). TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration. JCI Insight. 3(21). 92 indexed citations
13.
Li, Zhilian, Yan Li, Jessica M. Overstreet, et al.. (2018). Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes. Diabetes. 67(9). 1847–1857. 63 indexed citations
14.
Overstreet, Jessica M., Yinqiu Wang, Xin Wang, et al.. (2017). Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis. The FASEB Journal. 31(10). 4407–4421. 52 indexed citations
15.
Zhang, Ming‐Zhi, Xin Wang, Yinqiu Wang, et al.. (2016). IL-4/IL-13–mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney International. 91(2). 375–386. 156 indexed citations
16.
Wang, Xin, Bing Yao, Yinqiu Wang, et al.. (2016). Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy. Diabetes. 66(2). 494–504. 75 indexed citations
17.
Wang, Yinqiu, Jian Chang, Bing Yao, et al.. (2015). Proximal tubule-derived colony stimulating factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury. Kidney International. 88(6). 1274–1282. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026